Zimmer Biomet Holdings, Inc.
ZBH
$97.52
-$0.03-0.03%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.01B | 7.83B | 7.70B | 7.68B | 7.60B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.01B | 7.83B | 7.70B | 7.68B | 7.60B |
| Cost of Revenue | 2.28B | 2.26B | 2.23B | 2.19B | 2.14B |
| Gross Profit | 5.73B | 5.57B | 5.47B | 5.49B | 5.46B |
| SG&A Expenses | 3.08B | 2.97B | 2.90B | 2.88B | 2.86B |
| Depreciation & Amortization | 645.70M | 617.40M | 600.80M | 591.90M | 579.20M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.45B | 6.30B | 6.17B | 6.09B | 6.01B |
| Operating Income | 1.56B | 1.54B | 1.53B | 1.59B | 1.58B |
| Income Before Tax | 1.02B | 973.20M | 1.05B | 1.04B | 1.03B |
| Income Tax Expenses | 214.60M | 147.70M | 135.60M | 131.40M | -52.70M |
| Earnings from Continuing Operations | 807.40 | 825.50 | 915.20 | 905.40 | 1.08K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -2.20M | -2.10M | -1.80M | -1.60M | -1.40M |
| Net Income | 805.20M | 823.40M | 913.40M | 903.80M | 1.08B |
| EBIT | 1.56B | 1.54B | 1.53B | 1.59B | 1.58B |
| EBITDA | 2.63B | 2.58B | 2.55B | 2.58B | 2.56B |
| EPS Basic | 4.06 | 4.12 | 4.53 | 4.45 | 5.27 |
| Normalized Basic EPS | 3.97 | 3.96 | 4.00 | 4.16 | 4.12 |
| EPS Diluted | 4.03 | 4.10 | 4.51 | 4.44 | 5.26 |
| Normalized Diluted EPS | 3.96 | 3.95 | 3.98 | 4.15 | 4.10 |
| Average Basic Shares Outstanding | 794.00M | 798.20M | 806.00M | 812.30M | 821.10M |
| Average Diluted Shares Outstanding | 796.70M | 800.90M | 809.00M | 815.50M | 824.20M |
| Dividend Per Share | 0.96 | 0.96 | 0.96 | 0.96 | 0.96 |
| Payout Ratio | 23.70% | 23.38% | 21.28% | 21.69% | 18.29% |